Sotera Health Company (SHC) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 11 Buy, 1 Hold.
The consensus price target is $22.67 (low: $20.00, high: $24.00), representing an upside of 42.3% from the current price $15.93.
Analysts estimate Earnings Per Share (EPS) of $0.69 and revenue of $1.10B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.16 vs est $0.69 (missed -76.9%). 2025: actual $0.27 vs est $0.84 (missed -67.8%). Analyst accuracy: 0%.
SHC Stock — 12-Month Price Forecast
$22.67
▲ +42.31% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Sotera Health Company, the average price target is $22.67, with a high forecast of $24.00, and a low forecast of $20.00.
The average price target represents a +42.31% change from the last price of $15.93.
Highest Price Target
$24.00
Average Price Target
$22.67
Lowest Price Target
$20.00
SHC Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Sotera Health Company in the past 3 months
EPS Estimates — SHC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.16
vs Est $0.69
▼ 333.3% off
2025
Actual $0.27
vs Est $0.84
▼ 210.7% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — SHC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.100B
vs Est $1.101B
▼ 0.1% off
2025
Actual $1.164B
vs Est $1.160B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
